These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6669911)

  • 21. NIBSC (National Institute for Biological Standards and Control) Clare Hall.
    J Inst Hosp Eng; 1988 Jun; 42(5):13-4. PubMed ID: 10287658
    [No Abstract]   [Full Text] [Related]  

  • 22. [The creation of a national reference laboratory].
    Delektorskaia LN
    Lab Delo; 1990; (11):11-2. PubMed ID: 1704943
    [No Abstract]   [Full Text] [Related]  

  • 23. Carrying out the responsibility to industry relative to animal biologics.
    Hejl JM
    Proc Annu Meet U S Anim Health Assoc; 1967; 71():50-60. PubMed ID: 5257329
    [No Abstract]   [Full Text] [Related]  

  • 24. Statement of organization and functions. Final rule.
    Consumer Product Safety Commission
    Fed Regist; 2001 Jul; 66(142):38369. PubMed ID: 11725799
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Aims and tasks of a national reference laboratory].
    Titov VN
    Lab Delo; 1990; (11):4-7. PubMed ID: 1704955
    [No Abstract]   [Full Text] [Related]  

  • 26. The National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention: a new administrative structure for schistosomiasis control.
    Zhou XN; Chen JX; Chen MG; Bergquist R
    Acta Trop; 2005; 96(2-3):296-302. PubMed ID: 16126154
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Summary of Veterinary Services tests of biologics 1978-1979.
    Price RJ
    Proc Annu Meet U S Anim Health Assoc; 1979; (83):63-5. PubMed ID: 298938
    [No Abstract]   [Full Text] [Related]  

  • 28. [A national reference laboratory (the opinion of a chief specialist in the USSR)].
    Kolb VG
    Lab Delo; 1990; (11):10-1. PubMed ID: 1704942
    [No Abstract]   [Full Text] [Related]  

  • 29. [Building and implementation of management system in laboratories of the National Institute of Hygiene].
    Rozbicka B; Brulińska-Ostrowska E
    Rocz Panstw Zakl Hig; 2008; 59(4):381-8. PubMed ID: 19227248
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Unifying abbreviations for biologics in rheumatology--does the idea hold promise?
    Müller-Ladner U
    Rheumatology (Oxford); 2009 Jun; 48(6):704. PubMed ID: 19304793
    [No Abstract]   [Full Text] [Related]  

  • 31. Biologics for inflammatory bowel disease: drug approval and monitoring in the United States.
    Tremaine WJ
    Gastroenterol Clin North Am; 2006 Dec; 35(4):735-41. PubMed ID: 17129810
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Problems in the control of certain biological products.
    Outschoorn AS; Perkins FT; van Ramshorst JD
    WHO Chron; 1969 Dec; 23(12):554-5. PubMed ID: 5366446
    [No Abstract]   [Full Text] [Related]  

  • 33. Key elements of government contracting: an untapped resource for hospital outreach revenues.
    Harris A
    Clin Leadersh Manag Rev; 2001; 15(4):249-56. PubMed ID: 11490655
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SUBPART F--drug testing laboratories.
    Occup Health Saf; 2000 Apr; 69(4):40-6, 109. PubMed ID: 11396026
    [No Abstract]   [Full Text] [Related]  

  • 35. The transmissible spongiform encephalopathy agents: concerns and responses of United States regulatory agencies in maintaining the safety of biologics.
    Asher DM
    Dev Biol Stand; 1999; 100():103-18. PubMed ID: 10616181
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Scientific and regulatory considerations on the immunogenicity of biologics.
    Shankar G; Shores E; Wagner C; Mire-Sluis A
    Trends Biotechnol; 2006 Jun; 24(6):274-80. PubMed ID: 16631266
    [TBL] [Abstract][Full Text] [Related]  

  • 37. WHO Expert Committee on Biological Standardization. Forty-sixth Report.
    World Health Organ Tech Rep Ser; 1998; 872():i-vii, 1-90. PubMed ID: 9615608
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The work of the OIE Biological Standards Commission.
    Edwards S
    Dev Biol (Basel); 2007; 128():5-11. PubMed ID: 18084921
    [TBL] [Abstract][Full Text] [Related]  

  • 39. How we manage clinical trials in the cellular therapy laboratory.
    Tanhehco YC; Schwartz J
    Transfusion; 2018 Jan; 58(1):8-15. PubMed ID: 28940293
    [No Abstract]   [Full Text] [Related]  

  • 40. [Basis for the organization of public health laboratories].
    Arévalo Alonso JM
    Rev Sanid Hig Publica (Madr); 1978; 52(1-2):177-86. PubMed ID: 725476
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.